How would you use non-mon (MMS/LP) features in the three usage scenarios in the draft charter? Each scenario includes the merging of rulesets created without knowledge of what they would be merged with. I don't see how you can do that safely with a non-monotonic logic. If a drug-interaction rulebase relies on any kind of non-mon feature, then it's quite possible to give incorrect results when the pharmacy merges it with another drug rulebase. This doesn't exactly require non-mon to be out of scope, but it seems to justify a monotonic logic (eg FOL) as the primary deliverable. -- sandroReceived on Friday, 26 August 2005 19:42:56 GMT
This archive was generated by hypermail 2.2.0+W3C-0.50 : Tuesday, 8 January 2008 14:16:23 GMT